v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net income $ 65,782,000 $ 59,364,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Net discount accretion (14,542,000) (17,601,000)
Depreciation and amortization expense 10,385,000 11,622,000
Provision for credit losses - loans 2,192,000 51,000
Recovery of credit losses - unfunded loan commitments (460,000) (100,000)
Share-based compensation 4,426,000 3,976,000
Gains on sales of loans originated for sale (607,000) (841,000)
Fair value adjustments on loans held for sale 178,000 (31,000)
Mortgage loans originated for sale (33,204,000) (40,043,000)
Proceeds from sales of loans originated for sale 35,799,000 41,503,000
Gain on OREO and premises held for sale (155,000) (119,000)
Gain on disposal of premises and equipment 0 (7,000)
Deferred income tax expense 1,486,000 6,646,000
Net Investment securities gains (70,000) (71,000)
Payment of legal settlement (478,000) 0
Net (gains) losses on derivatives (918,000) 343,000
Income from life insurance (6,547,000) (4,071,000)
(Increase) decrease in accrued interest receivable and other assets (20,521,000) 7,948,000
Increase (decrease) in accrued interest payable and other liabilities 1,329,000 (11,147,000)
Other, net 1,137,000 823,000
Net cash provided by operating activities 45,212,000 58,245,000
Cash flows from investing activities    
Proceeds from sales of AFS securities 0 41,647,000
Maturities, repayments and calls of AFS securities 77,553,000 60,462,000
Purchases of AFS securities (86,447,000) (147,333,000)
Net purchases of restricted investments in bank stocks (5,797,000) (3,879,000)
Net increase in loans (179,685,000) (32,764,000)
Investment in limited partnerships (887,000) (1,285,000)
Purchases of bank premises and equipment (1,619,000) (3,611,000)
Proceeds from disposal of OREO and premises held for sale 1,216,000 2,182,000
Proceeds from disposal of premises and equipment 0 18,000
Purchases of bank owned life insurance (814,000) 0
Death benefit proceeds from life insurance contracts 4,923,000 864,000
Other 0 (15,000)
Net cash used in investing activities (191,557,000) (83,714,000)
Cash flows from financing activities    
Net increase (decrease) in deposits 52,999,000 (90,387,000)
Net increase in borrowings with original maturities less than 90 days 218,059,000 95,538,000
Proceeds from FHLB advances with original maturities greater than 90 days 0 20,000,000
Payments on FHLB advances with original maturities greater than 90 days (100,000,000) (15,000,000)
Settlement of terminated derivatives 1,635,000 0
Payments on subordinated notes (31,000,000) (32,500,000)
Dividends paid (17,648,000) (15,378,000)
Acquisition of treasury stock (429,000) (94,000)
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting (1,567,000) (2,001,000)
Proceeds from issuance of employee stock purchase plan shares 172,000 151,000
Other (4,000) 412,000
Net cash provided by (used in) financing activities 122,217,000 (39,259,000)
Net decrease in cash and cash equivalents (24,128,000) (64,728,000)
Cash and cash equivalents at beginning of period 149,774,000 248,874,000
Cash and cash equivalents at end of period 125,646,000 184,146,000
Cash paid during the period for:    
Interest 76,414,000 78,082,000
Income taxes 5,450,000 2,200,000
Supplemental schedule of noncash activities:    
Lease liabilities arising from obtaining ROU assets $ 0 $ 2,010,000